| Immune suppression in gliomas MM Grabowski, EW Sankey, KJ Ryan, P Chongsathidkiet, SJ Lorrey, ... Journal of neuro-oncology 151, 3-12, 2021 | 217 | 2021 |
| CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in … QT Ostrom, M Price, K Ryan, J Edelson, C Neff, G Cioffi, KA Waite, ... Neuro-oncology 24 (Supplement_3), iii1-iii38, 2022 | 162 | 2022 |
| Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019 M Price, K Ryan, ML Shoaf, C Neff, JB Iorgulescu, DB Landi, G Cioffi, ... Neuro-Oncology Practice 11 (1), 5-25, 2024 | 9 | 2024 |
| D2C7-CAR: A NOVEL, DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR/EGFRVIII GLIOBLASTOMA AND EGFR OVER … Z Wilson, D Wilkinson, K Ryan, V Chandramohan, D Bigner, P Fecci NEURO-ONCOLOGY 25, 2023 | 1 | 2023 |
| Impact of Mindfulness-Based Stress Management Training on Perceived Stress and Burnout Amongst Pediatric Trainees: A Pilot Study KJ Ryan, A Shad Pediatrics 142 (1_MeetingAbstract), 90-90, 2018 | 1 | 2018 |
| SYST-14 D2C7 CAR EFFECTIVELY AND SAFELY TREATS EGFRWT AND EGFRVIII-EXPRESSING TUMORS FOLLOWING INTRACRANIAL ADMINISTRATION D Wilkinson, J Wilson, E Lerner, K Ryan, V Chandramohan, D Landi, ... Neuro-Oncology Advances 5 (Suppl 3), iii30, 2023 | | 2023 |
| A NOVEL DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR EXPRESSING MEDULLOBLASTOMA J Wilson, D Wilkinson, K Ryan, D Bigner, V Chambramohan, P Fecci NEURO-ONCOLOGY 24, 228-229, 2022 | | 2022 |
| Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly WB Hannah, K Ryan, S Pendyal, TA Burrow, SE Harley, M Cordell, ... American Journal of Medical Genetics Part A 188 (11), 3364-3368, 2022 | | 2022 |
| SYST-12 D2C7 CAR: A NOVEL CAR T CELL THAT SIMULTANEOUSLY TARGETS WILDTYPE EGFR AND ITS MUTANT ISOFORM EGFRVIII FOR TREATMENT OF GLIOMA AND BRAIN METASTASES D Wilkinson, K Ryan, J Wilson, V Chandramohan, D Bigner, P Fecci Neuro-oncology Advances 4 (Suppl 1), i23, 2022 | | 2022 |
| D2C7 CAR: A novel CAR T cell that simultaneously targets wildtype EGFR and its mutant isoform EGFRvIII for treatment of glioma DS Wilkinson, K Ryan, J Wilson, V Chandramohan, D Landi, D Bigner, ... The Journal of Immunology 208 (1_Supplement), 122.03-122.03, 2022 | | 2022 |
| EXTH-59. GENERATION OF A THIRD GENERATION CAR T CELL THAT SIMULTANEOUSLY TARGETS WILDTYPE EGFR AND ITS MUTANT ISOFORM EGFRVIII FOR TREATMENT OF GLIOBLASTOMA D Wilkinson, K Ryan, V Chandramohan, D Landi, D Bigner, P Fecci Neuro-Oncology 23 (Suppl 6), vi176, 2021 | | 2021 |
| DDRE-20. GENERATION OF A HIGH-AFFINITY EGFR/EGFRvIII-TARGETED D2C7 CAR-T CELL K Ryan, D Wilkinson, D Landi, P Fecci Neuro-Oncology 22 (Suppl 2), ii65, 2020 | | 2020 |
| A RARE CASE OF PRIMARY POLYCYTHEMIA VERA IN A PEDIATRIC PATIENT K Ryan, K Kaiser, A Shad PEDIATRIC BLOOD & CANCER 65, 2018 | | 2018 |
| Workshop Session Abstracts K Ryan, E Rader, M Price, D Cromey, P Hockberger Journal of Biomolecular Techniques: JBT 24 (Suppl), S20-S21, 2013 | | 2013 |
Matthew M Grabowski, MDCleveland Clinic, Lerner Research Institute在 ccf.org 的电子邮件经过验证
